KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Alnylam Pharmaceuticals (ALNY) over the last 13 years, with Q4 2025 value amounting to $1.7 million.

  • Alnylam Pharmaceuticals' Treasury Shares rose 63.77% to $1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 million, marking a year-over-year increase of 63.77%. This contributed to the annual value of $1.7 million for FY2025, which is 63.77% up from last year.
  • According to the latest figures from Q4 2025, Alnylam Pharmaceuticals' Treasury Shares is $1.7 million, which was up 63.77% from $1.7 million recorded in Q4 2024.
  • In the past 5 years, Alnylam Pharmaceuticals' Treasury Shares registered a high of $1.7 million during Q4 2025, and its lowest value of $1.0 million during Q4 2023.
  • In the last 5 years, Alnylam Pharmaceuticals' Treasury Shares had a median value of $1.2 million in 2022 and averaged $1.4 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 1355.65% in 2023, then skyrocketed by 6698.94% in 2024.
  • Quarter analysis of 5 years shows Alnylam Pharmaceuticals' Treasury Shares stood at $1.1 million in 2021, then grew by 5.19% to $1.2 million in 2022, then fell by 13.56% to $1.0 million in 2023, then surged by 66.99% to $1.7 million in 2024, then grew by 0.64% to $1.7 million in 2025.
  • Its Treasury Shares was $1.7 million in Q4 2025, compared to $1.7 million in Q4 2024 and $1.0 million in Q4 2023.